BioNTech vaccine mass production in China close to ready, may get go-ahead before July – Global Times
(April 23): The COVID-19 mRNA vaccine co-developed by German-based BioNTech and China’s Fosun Pharma can be rolled out in the Chinese mainland very quickly once it receives authorization, as key steps for mass production are close to ready, the Global Times learned from a source on Thursday.
It is highly likely that the vaccine, named BNT162b2, will be approved in China before July, the source said, noting that relevant preparations including the production plant and cold-chain delivery drills are in progress, Global Times reported.
On Wednesday, Shanghai Party chief Li Qiang held a virtual conference with BioNTech founder and CEO Uğur Şahin, a positive sign for the vaccine’s landing in the city, some observers said.
Source : The Edge Market
https://majusaham.com/biontech-vaccine-mass-production-in-china-close-to-ready-may-get-go-ahead-before-july-global-times/
